Join us in welcoming the newest members of the Olema team, Jean Pierre-Louis and Sophia Fanucchi, PHR! We're excited to have them on board and look forward to the incredible contributions they'll make as we seek to help patients living with cancer feel better - longer. Ready to take your next step in #biotech? Explore our open positions today: https://bit.ly/3MtjpoD #BreastCancerAndBeyond #NewHires #BiotechJobs #BreastCancerResearch #WomensOncology #BreastCancer
关于我们
Olema Oncology is a cancer medicines company dedicated to impacting breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a differentiated oral medicine known as a complete estrogen receptor antagonist (CERAN) initially in development for metastatic breast cancer. Our pipeline also includes OP-3136, a potent, selective oral inhibitor of the KAT6 pathway. At Olema, we are building a focused team committed to our mission with intention and clarity. Working alongside a talented, passionate group of leaders and advisors, we strive to create better medicines that aim to help patients feel better, longer. For more information, visit us at www.olema.com.
- 网站
-
https://olema.com
Olema Oncology的外部链接
- 所属行业
- 生物技术研究
- 规模
- 51-200 人
- 总部
- San Francisco,California
- 类型
- 上市公司
- 创立
- 2007
- 领域
- pharmaceuticals、biotechnology、drug development、oncology、breast cancer、nuclear receptors和small molecules
地点
Olema Oncology员工
动态
-
Here we come, San Antonio! We're pleased to share that data from our ongoing Phase 1b/2 study of palazestrant in combination with ribociclib will be presented at #SABCS24. Get the full details here: https://bit.ly/417qpSH
-
Are you a skilled clinical trial leader passionate about advancing women's oncology treatments? Join Olema as our new Senior Manager, Clinical Trial Lead! In this role, you'll manage clinical trial operations, oversee vendors, and ensure compliance to drive impactful results. Learn more about this opportunity and apply today: https://bit.ly/3MtjpoD #BreastCancerAndBeyond #Hiring #NowHiring #Biotech #BiotechJobs #ClinicalJobs #WomensOncology #BreastCancer #BreastCancerResearch
-
$OLMA We're in #London at the Jefferies Global Healthcare Conference! Senior management will participate in a fireside chat today from 1:30-1:55PM GMT. Tune into the conversation here: https://bit.ly/3Mr1zmw #BreastCancerAndBeyond #JefferieshHealthcare #Biotech #WomensOncology #CancerResearch #BreastCancerResearch #ClinicalResearch #BreastCancer
-
Step into leadership at Olema as our #AssociateDirector of Clinical Documentation and Trial Master File! Based in our #SanFrancisco or #Cambridge office, you'll oversee TMF, optimize Veeva eTMF technology, and ensure clinical document quality to drive impact in #BreastCancerAndBeyond. If you're an expert ready to contribute to #BreastCancerResearch, we want to hear from you. Apply today: https://bit.ly/3YQhUJ0 #Hiring #BiotechJobs #ClinicalDocumentation #WomensOncology #CancerResearch #OncologyCareers #OncologyResearch
-
We're #hiring! Join our #ClinicalDevelopment teams and work together with us to develop innovative medicines in #BreastCancerAndBeyond. Learn about the opportunities available to you and make your mark today: https://bit.ly/3CtOcSJ #NowHiring #Biotech #BiotechJobs #ClinicalJobs #WomensOncology #BreastCancer #BreastCancerResearch
-
$OLMA: Today we announced our Q3 2024 financial and operating results. Team Olema has much to be proud of as we remain on-track with our Phase 3 OPERA-01 trial and our #IND submission for OP-3136, presented three new preclinical data sets at #ENA24, and prepare to present updated palazestrant plus ribociclib combo data at #SABCS24. Read the full details here: https://bit.ly/40Kxw3l
-
Nothing like a day at the ballpark to recharge and connect! Our team enjoyed some sunshine, laughter, and a great game. Here’s to teamwork, both in the office and out in the stands! #BreastCancer #BreastCancerResearch #WomensOncology #Oncology #Biotech
-
Thank you to everyone who joined us at the Susan G. Komen Boston More Than Pink Walk! We're honored to have been part of such an inspiring day. Every step taken and every donation made brings us closer to our goal of helping patients with #breastcancer feel better, longer. #BreastCancerAwarenessMonth #BreastCancerAwareness #WomensOncology #Biotech #BreastCancerResearch
-
Last week at #ENASymp24, we had the privilege of engaging in scientific exchange with global leaders in cancer research about the latest innovations in drug development, target selection, and the impact of new discoveries in molecular biology—including our own! It was inspiring to learn from fellow innovators in #Biotech, and we look forward to connecting again next year. Check out our posters here: https://bit.ly/3Ai8QEw #WomensOncology #BreastCancerAwarenessMonth #BreastCancerAwareness #CancerResearch #ClinicalResearch #BreastCancerResearch